Prot#18-0431: A Multi-Center, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial of Mepolizumab for Treatment of Adults and Adolescents with Active Eosinophilic Esophagitis and Dysphagia-Predominant Symptoms

Project: Research project

Project Details

StatusActive
Effective start/end date2/18/202/18/23

Funding

  • University of North Carolina at Chapel Hill (Prot# 18-0431)
  • GlaxoSmithKline LLC (Prot# 18-0431)